References
- Rabe KF, Hurd S, Anzueto A, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–535.
- Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Revised 2011). www.goldcopd.org. Date last updated: December 2011. Date last accessed: April 2, 2012.
- Celli BR, Cote CG, Marín JM, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–1012.
- Ong KC, Earnest A, Lu SJ. A multi-dimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005; 128:3810–3816.
- Cote CG, Dordelly LJ, Celli BR. Impact of exacerbations on patient-centered outcomes. Chest 2007; 131:696–704.
- Martinez FJ, Foster G, Curtis JL, Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326–1334.
- Azarisman MS, Anshar Fauzi M, Ahmad Faizal MP, The SAFE (SGRQ score, air-flow limitation and exercise tolerance) index: A new composite score for the stratification of severity in chronic obstructive pulmonary disease. Postgrad Med J 2007; 83:492–497.
- Jones RC, Donaldson GC, Chavannes NH, Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease. The DOSE index. Am J Respir Crit Care Med 2009; 180:1189–1195.
- Puhan MA, Garcia-Aymerich J, Frey M, Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374:704–711.
- Soler-Cataluña JJ, Martínez-García MA, Sánchez Sánchez L, Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009; 103:692–699.
- Van Dijk WD, Bemt L, Haak-Rongen S, Multi-dimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res 2011; 12:151.
- Mahler DA, Criner GJ. Assessment tools for chronic obstructive pulmonary disease. Do newer metrics allow for disease modification? Proc Am Thorac Soc 2007; 4:507–511.
- Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006; 130:1117–1128.
- Hoogendoorn M, Rutten-van Mölken MP, Hoogenveen RT, A dynamic population model of disease progression in chronic obstructive pulmonary disease. Eur Respir J 2005; 26:223–233.
- Miravitlles M, Soriano JB, Garcia-Rio F, Prevalence of COPD in Spain and impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64:863–868.
- Vilaró J, Gimeno E, Sánchez Férez N, Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios. Med Clin (Barc) 2007; 129:326–332.
- Garcia-Rio F, Miravitlles M, Soriano JB, Systemic inflammation in chronic obstructive pulmonary disease: A population-based study. Respir Res 2010; 11:63.
- ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–116.
- Oga T, Tsukino M, Hajiro T, Predictive properties of diferent multi-dimensional staging systems in patients with chronic obstructive pulmonary disease. Int J COPD 2011; 6:521–526.
- Briggs A, Spence M, Wang H, Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Intern Med 2008; 168:71–79.
- Niewoehner DE, Lokhnygina Y, Rice K, Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007; 131:20–28.
- Esteban C, Quintana JM, Moraza J, BODE-index vs HADO-score in chronic obstructive pulmonary disease: which one to use in general practice? BMC Med 2010; 8:28.
- Garcia-Rio F, Lores V, Mediano O, Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180:506–512.
- Garrod R, Bestall JC, Paul EA, Development and validation of a standardized measure of activity of daily liging in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000; 94:589–596.
- Watz H, Waschki B, Meyer T, Decreasing cardiac chamber sizes and associated heart dysfunction in COPD. Role of hyperinflation. Chest 2010; 138:32–38.
- Garcia-Rio F, Rojo B, Casitas R, Prognostic value of the objective measurement of daily physical activity in COPD patients. Chest 2012; 142:338–46.
- Mahler DA, Weinberg DH, Wells CK, The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85:751–758.
- Hajiro T, Nishimura K, Tsukino M, Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:785-90.
- Punekar YS, Rodriguez-Roisin R, Sculpher M, Implications of chronic obstructive pulmonary disease (COPD) on patients health status: A western view. Respir Med 2007; 101:661–669.
- Van Manen JG, Bindels PJ, Dekker FW, The influence of COPD on health-related quality of life independent of the influence of co-morbidity. J Clin Epidemiol 2003; 56:1177–1184.